Evidence map›Paper›PMID 23802702›Full record

ArticleJournal of the American Chemical Society2013

Sc3+-triggered oxoiron(IV) formation from O2 and its non-heme iron(II) precursor via a Sc3+-peroxo-Fe3+ intermediate.

Feifei Li, Katherine M Van Heuvelen, Katlyn K Meier, Eckard Münck, Lawrence Que

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Article
  3. ScJournal of the American Chemical Society · 2020
    Article
  4. Article
  5. Article
  6. Activation of a Non-Heme FeAngewandte Chemie (International ed. in English) · 2019
    Article
  7. Review
  8. Article
  9. HACS catalysis · 2018
    Article
  10. Article
  11. Review
  12. ScJournal of the American Chemical Society · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Feifei LiDepartment of Chemistry and Center for Metals in Biocatalysis, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Katherine M Van Heuvelen
Katlyn K Meier
Eckard Münck
Lawrence Que
University of Minnesota · USCarnegie Mellon University · US

Funding

Study of O2 Activation by Mossbauer SpectroscopyR01EB001475 · NIBIB · CARNEGIE-MELLON UNIVERSITY · PI MUNCK, ECKARD · 2003 to 2011
$2.9M
Nonheme Iron(III)-Superoxo Compounds: Preparation and Characterization of MoleculF32GM093479 · NIGMS · UNIVERSITY OF MINNESOTA · PI VAN HEUVELEN, KATHERINE MARIE · 2010 to 2011
$94k
NIBIB NIH HHS EB001475NIBIB NIH HHS R01 EB001475NIGMS NIH HHS F32 GM093479NIGMS NIH HHS GM093479
6 · The paper itself

Abstract

We report that redox-inactive Sc(3+) can trigger O2 activation by the Fe(II)(TMC) center (TMC = tetramethylcyclam) to generate the corresponding oxoiron(IV) complex in the presence of BPh4(-) as an electron donor. To model a possible intermediate in the above reaction, we generated an unprecedented Sc(3+) adduct of [Fe(III)(η(2)-O2)(TMC)](+) by an alternative route, which was found to have an Fe(3+)-(μ-η(2):η(2)-peroxo)-Sc(3+) core and to convert to the oxoiron(IV) complex. These results have important implications for the role a Lewis acid can play in facilitating O-O bond cleavage during the course of O2 activation at non-heme iron centers.

Indexed as

Ferrous CompoundsOrganometallic CompoundsOxygenScandiumFerrous CompoundsOrganometallic CompoundsOxygenScandium

Identifiers

PMID23802702
PMCPMC3760346
OpenAlexW2001557961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.